NCT01680991: A Study of Obinutuzumab in Chinese Participants With CD20+ Malignant Disease |
|
|
| Completed | 1 | 48 | RoW | Obinutuzumab, RO5072759, GA101 | Hoffmann-La Roche | Lymphocytic Leukemia, Chronic, Diffuse Large B-cell Lymphoma, Follicular Lymphoma | 12/14 | 12/14 | | |